期刊文献+

不同膳食脂肪酸对大鼠肝脏SREBP-1c基因表达和非酒精性脂肪肝发生的影响 被引量:4

Effects of dietary fatty acids on expression of gene sterol-regulatory elementary binding protein-1c and occurrence of non-alcoholic fatty liver disease in rats
下载PDF
导出
摘要 目的探讨不同膳食脂肪酸构成对非酒精性脂肪肝(nonalcoholic fatty liver disease,NAFLD)发生、发展的影响及其与固醇调节元件结合蛋白-1c(SREBP-1c)的关系。方法 100只成年SD大鼠,按随机数字表法分为5组:对照组、NAFLD模型组、单不饱和脂肪酸组(monounsaturated fatty acid,MUFA)、n-6多不饱和脂肪酸组(n-6 polyunsaturated fatty acids,n-6 PUFA)和4∶1 n-6/n-3 PUFA组,每组20只。对照组用基础饲料喂养,其余各组饲料中加1%胆固醇和10%不同油脂(分别是10%猪油、10%橄榄油、10%玉米油、8%玉米油+2%鱼油)。分别于第8、16周时,采用HE染色观察肝脏脂肪变性情况,测定血清和肝脏中脂质含量,采用实时定量PCR分析SREBP-1c、FAS mRNA表达,Western blot检测SREBP-1c、FAS的蛋白表达。结果 NAFLD模型组大鼠体质量显著高于对照组和其他膳食脂肪酸组(P<0.05),模型组、MUFA组大鼠肝脏中TG含量显著高于对照组(P<0.05),而n-6 PUFA组和4∶1n-6/n-3 PUFA组大鼠血清中TG及肝脏中TC、TG浓度显著低于模型组(P<0.05);HE染色后,NAS量化评分显示模型组大鼠肝脏脂肪变性程度较对照组、MUFA组、n-6 PUFA组、4∶1 n-6/n-3 PUFA组严重;与对照组比较,NAFLD模型组大鼠肝脏SREBP-1c与FAS mRNA表达升高,MUFA组、n-6 PUFA组和4∶1 n-6/n-3 PUFA组SREBP-1c蛋白表达降低(P<0.05)。结论降低膳食中饱和脂肪酸,增加不饱和脂肪酸(尤其是适当比例的n-6/n-3 PUFA)可下调高脂喂养大鼠肝内SREBP-1c的表达,延缓高脂膳食引起的NAFLD发生、发展。 Objective To investigate the effects of dietary fatty acids on the development and progression of non-alcoholic fatty liver disease ( NAFLD ) and the correlation with the expression of sterol regulatory element binding protein-1 c (SREBP-1 c). Methods A total of 100 SD rats were randomly divided into 5 groups with different diets : control group ( standard-chow diet), NAFLD model group ( standard-chow diet with 10% lard and 1% cholesterol), mono-unsaturated fatty acid (MUFA) group (standard-chow diet with 10% olive oil and 1% cholesterol), n-6 poly-unsaturated fatty acid (n-6 PUFA) group (standard-chow diet with 10% corn oil and 1% cholesterol) , and 4:1 n-6/n-3 poly-unsaturated fatty acid (4:1 n-6/n-3 PUFA) group (standard-chow diet with 8% corn oil, 2% fish oil and 1% cholesterol). Each group had 20 rats. The hepatic steatosis was observed by hematoxylin and eosin (HE) staining after feeding for 8 and 16 weeks. The concentrations of total cholesterol (TC) and triglyceride (TG) in serum and liver were measured. The mRNA levels of SREBP-lc and FAS were measured by quantitative real-time PCR, and their protein levels by Western blotting. Results In NAFLD model group, the body mass of rats were significantly higher than that in control group and other groups ( P 〈 0.05 ). The TG level in the liver was significantly higher in NAFLD model group and MUFA group than that in control group (P 〈 0.05 ), but TG levels in the serum, and TC and TG levels in the liver in both n-6 PUFA group and 4:1 n-6/n-3PUFA group were significantly lower than those in NAFLD model group ( P 〈 0.05 ). HE staining showed that the fatty degeneration in NAFLD model group was more severe than in control group, MUFA group, n-6 PUFA group and 4:1 n-6/n-3 PUFA group. Compared to the control group, the expression levels of SREBP-1c and FAS were significantly higher in NAFLD model group, and the protein expression of SREBP-1 c was significantly lower in MUFA group, n-6 PUFA group and 4:1 n-6/n-3 PUFA group. Conclusion Increasing the amount of n-3 PUFA, particularly in a 4 : 1 ratio of n-6 PUFA to n-3 PUFA, and decreasing saturated fatty acid may prevent the occurrence and development of NAFLD in high-fat fed rats, which is partly modulated by down-regulation of SREBP-1 c.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2016年第18期2002-2007,共6页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(30972469)~~
关键词 膳食脂肪酸 固醇调节元件结合蛋白-1C 非酒精性脂肪肝 dietary fatty acid sterol regulatory element binding protein-1 c non-alcoholic fatty liver disease
  • 相关文献

参考文献21

  • 1Than N N, Newsome P N. A concise review of non-alcoholic fatty liver disease [ J ]. Atherosclerosis, 2015, 239 ( 1 ) : 192-202. DOI: 10. 1016/j. atherosclerosis. 2015.01. 001.
  • 2Singer C, Stancu P, Cosoveanu S, et al. Non-alcoholic Fatty liver disease in children [ J ]. Curr Health Sci J, 2014, 40 (3) : 170 - 176. DOI : 10.12865/CHSJ. 40.03.03.
  • 3Jiang C M, Pu C W, Hou Y H, et al. Non alcoholic steato- hepatitis a precursor for hepatoeellular carcinoma development [ J]. World J Gastroenterol, 2014, 20(44) : 16464 -16473. DOI: 10.3748/wig. v20. i44. 16464.
  • 4Arendt B M, Comelli E M, Ma D W, et al. Altered hepatic gene expression in nonalcoholic fatty liver disease is associat- ed with lower hepatic n-3 and n-6 polyunsaturated fatty acids [J]. Hepatology, 2015, 61 (5) : 1565 - 1578. DOI: 10. lO02/hep. 27695.
  • 5Cortez-Pinto H, Jesus L, Barros H, et al. How different is the dietary pattern in non-alcoholic steatohepatitis patients? [J]. Clin Nutr, 2006, 25(5) : 816 -823.
  • 6Jump D B, Depner C M, Tripathy S, et al. Potential for diet- ary to-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer [ J] Adv Nutr, 2015, 6(6): 694-702. DOI: 10.3945/an. 115.009423.
  • 7冉莉,万婧,张海英,陈诗慧,高燕翔,张乾勇,糜漫天.血浆游离脂肪酸组成与非酒精性脂肪性肝病的相关性研究[J].重庆医学,2014,43(14):1697-1699. 被引量:5
  • 8Alkhouri N. The use of omega-3 Fatty acids in nonalcoholic Fatty liver disease: the end of the road or a new beginning? [J]. J Pediatr, 2015, 166(6): 1335-1337. DOI: 10. lO16/j, jpeds. 2015.03. 003.
  • 9Gupta V, Mah X J, Garcia M C, et al. Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease [J ]. World J Gastroenterol, 2015, 21 (37) : 10621 - 10635. DOI: 10.3748/wjg. v21. i37. 10621.
  • 10Qin Y, Zhou Y, Chen S H, et al. Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Re- duction in Plasma Fibroblast Growth Factor 21 and Prosta-glandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial [ J ]. PLoS One, 2015, 10(7) : e0133496. DOI: 10. 1371/jour- nal. pone. 0133496.

二级参考文献23

  • 1Veronika Zámbó,Laura Simon-Szabó,Péter Szelényi,va Kereszturi,Gábor Bánhegyi,Miklós Csala.Lipotoxicity in the liver[J].World Journal of Hepatology,2013,5(10):550-557. 被引量:3
  • 2张坚,王春荣,高俊全,李筱薇,陈君石.我国居民膳食脂类摄入量的研究[J].营养学报,2004,26(3):167-171. 被引量:30
  • 3时皎皎,糜漫天,韦娜,王斌.不同脂肪酸构成比对大鼠血脂影响的研究[J].第三军医大学学报,2007,29(9):824-827. 被引量:20
  • 4Binukumar B, Mathew A. Dietary fat and risk of breast cancer [J] . World J Surg Oncol, 2005,18: 45-51.
  • 5Hardy S, St-Onge GG, Joly E, et al. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40 [J]. J Bio] Chem, 2005, 280: 13285-13291.
  • 6Yu FL, Greenlaw R, Fang Q, et al. Studies on the chemopreventive potentials of vegetable oils and unsaturated fatty acids against breast cancer carcinogenesis at initiation [J] . Eur J Cancer Prev, 2004, 13: 239-248.
  • 7Larsson SC, Kumlin M, Ingelman-Sundberg M, et al. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms [J]. Am J Clin Nutr, 2004, 79:935-945.
  • 8Jude S, Roger S, Martel E, et al. Dietary long-chain omega-3 fatty acid of marine origin: A comparison of their protective effects on coronary heart disease and breast cancers [J]. ProgBiophys Mol Biol, 2006, 90: 299-325.
  • 9Lu S, Zhang X, Badowi AF, et al. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids [J].Cancer Lett, 2002, 184: 7-12.
  • 10Jho DH, Cole SM, Lee EM, et al. Role of omega-3 fatty acid supplementation in inflammation and malignancy [J] . Integr Cancer Ther, 2004, 3:98-111.

共引文献21

同被引文献29

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部